Actavis first to market generic prostate cancer drug Bicalutamide in the UK, Germany & France

Actavis, the international generic pharmaceuticals company, recently launched Bicalutamide tablets in the UK, Germany and France. Acuavis Bicalutamide is the first generic version of the oncology drug to be made available in the three markets. Actavis has launched a generic drug for prostate cancer, Bicalutamide, in the UK, France and Germany. Bicalutamide, ... Read More...